Department of Translational Biomedicine and Neuroscience (DiBraiN), University of study of Bari Aldo Moro, Piazza G. Cesare, 11, 70124 Bari, Italy.
Molecular Medicine for Neurodegenerative and Neuromuscular Diseases Unit, IRCCS Stella Maris Foundation, Viale del Tirreno, 56128 Calambrone, Pisa, Italy.
Hum Mol Genet. 2024 Apr 18;33(9):768-786. doi: 10.1093/hmg/ddae008.
In several cases of mitochondrial diseases, the underlying genetic and bioenergetic causes of reduced oxidative phosphorylation (OxPhos) in mitochondrial dysfunction are well understood. However, there is still limited knowledge about the specific cellular outcomes and factors involved for each gene and mutation, which contributes to the lack of effective treatments for these disorders. This study focused on fibroblasts from a patient with Autosomal Dominant Optic Atrophy (ADOA) plus syndrome harboring a mutation in the Optic Atrophy 1 (OPA1) gene. By combining functional and transcriptomic approaches, we investigated the mitochondrial function and identified cellular phenotypes associated with the disease. Our findings revealed that fibroblasts with the OPA1 mutation exhibited a disrupted mitochondrial network and function, leading to altered mitochondrial dynamics and reduced autophagic response. Additionally, we observed a premature senescence phenotype in these cells, suggesting a previously unexplored role of the OPA1 gene in inducing senescence in ADOA plus patients. This study provides novel insights into the mechanisms underlying mitochondrial dysfunction in ADOA plus and highlights the potential importance of senescence in disease progression.
在几种线粒体疾病中,线粒体功能障碍中氧化磷酸化(OxPhos)减少的潜在遗传和生物能原因已得到充分理解。然而,对于每个基因和突变,关于具体的细胞结果和涉及的因素仍然知之甚少,这导致缺乏针对这些疾病的有效治疗方法。本研究专注于患有常染色体显性视神经萎缩(ADOA)加综合征的患者的成纤维细胞,该患者携带视神经萎缩 1 (OPA1)基因突变。通过结合功能和转录组学方法,我们研究了线粒体功能,并确定了与疾病相关的细胞表型。我们的研究结果表明,具有 OPA1 突变的成纤维细胞表现出线粒体网络和功能的破坏,导致线粒体动力学改变和自噬反应减少。此外,我们观察到这些细胞出现过早衰老表型,表明 OPA1 基因在诱导 ADOA 加患者衰老中具有以前未知的作用。这项研究为 ADOA 加中线粒体功能障碍的机制提供了新的见解,并强调了衰老在疾病进展中的潜在重要性。